Medication Fact Sheets
|
December 4, 2024

Farxiga Guide: How It Works to Improve Health

Medically Reviewed by
Updated On
December 9, 2024

New data released by the Lancet in November 2024 demonstrated that the global incidence of diabetes has quadrupled since 1990, affecting nearly 800 million people globally. Finding effective means to manage diabetes as well as cardiovascular and kidney health has never been more important. 

Farxiga (dapagliflozin) is a medication that not only lowers blood sugar but also improves cardiovascular and kidney health. With millions affected by Type 2 diabetes and its complications, Farxiga offers a comprehensive approach to treatment. 

This guide will explore what Farxiga is, how it works, its benefits, potential risks, and frequently asked questions, as well as listing other lifestyle factors to support cardiovascular and metabolic health.

[signup]

What is Farxiga (Dapagliflozin)?

Farxiga is a medication designed to address multiple health challenges in people with diabetes and related conditions, such as cardiovascular and kidney disease.

Drug Class

Farxiga belongs to the sodium-glucose cotransporter-2 (SGLT2) inhibitor class of drugs. SGLT2 inhibitors work by targeting how the kidneys regulate blood sugar.

Mechanism of Action

Farxiga blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption into the bloodstream. This allows excess glucose to be excreted through urine. Additionally, Farxiga reduces fluid retention, which benefits heart and kidney health by decreasing strain on these organs.

Brand Name vs. Generic

Farxiga is the brand name for dapagliflozin. 

FDA-Approved Indications

Farxiga is FDA-approved for:

  • Blood sugar control in adults with Type 2 diabetes.
  • Reducing the risk of hospitalization for heart failure.
  • Slowing the progression of chronic kidney disease in adults.

Off-Label Indications

Farxiga is also used off-label for some patients in the following situations:

  • Management of heart failure with New York Heart Association functional class II-IV reduced ejection fraction (HFrEF).

Key Benefits of Farxiga (Dapagliflozin)

Farxiga has important benefits for people living with chronic conditions such as diabetes, cardiovascular disease and kidney disease.

Blood Glucose Control

Farxiga effectively lowers blood sugar levels, as reflected in lowered HbA1c levels at 6 months of use. 

Cardiovascular Benefits

Farxiga (dapagliflozin) is approved to treat heart failure with reduced ejection fraction (HFrEF). It helps lower the risk of death from heart-related causes, hospitalizations, and worsening heart failure in people with or without Type 2 diabetes, while also improving symptoms and being generally safe to use.

Kidney Protection

Farxiga slows the progression of chronic kidney disease, even in patients without diabetes. By reducing protein loss in urine and improving kidney function, it provides critical support for long-term health.

Additional Benefits

  • Weight Loss: Farxiga helps reduce body weight by targeting fat loss while preserving muscle mass in people with type 2 diabetes. Over six months of treatment, it improved blood sugar levels, lowered total and visceral fat, and reduced fat buildup in muscles without causing muscle loss. 
  • Use in Patients Without Diabetes: Farxiga helps manage heart failure in patients with and without diabetes.

Who Should Take Farxiga?

The following groups of people may benefit from Farxiga:

Indications

Farxiga is prescribed for patients with:

Contraindications

Farxiga is not suitable for:

  • Patients with severe kidney impairment or on dialysis
  • Those with a history of hypersensitivity to dapagliflozin

Prescribing Considerations

Clinicians assess patient history, cardiovascular risks, and kidney function before prescribing Farxiga. Regular monitoring ensures its safety and effectiveness.

How to Take Farxiga (Dapagliflozin)

It’s important to follow the directions given by your healthcare provider exactly. 

Dosage Guidelines

The typical starting dose is 5 mg once daily, which may be increased based on individual response and tolerability.

Administration Tips

Farxiga can be taken with or without food.

Maintaining hydration is essential to reduce the risk of dehydration.

Missed Dose and Overdose

Follow the instructions given by your healthcare provider. See below for missed dose and overdose:

Missed Dose: take your medication as soon as you remember, unless it's close to your next dose. Never double up.

Overdose: seek immediate medical attention if symptoms like severe dehydration or dizziness occur.

Potential Side Effects and Risks

Like any medication, Farxiga carries the risk of side effects.

Common Side Effects

The following side effects can be common in patients taking Farxiga:

  • Yeast Infections: especially common in women due to similar mechanisms as UTIs; this side effect can also occur in men.
  • Dehydration: can lead to dizziness or low blood pressure.

Serious Side Effects

The following side effects warrant immediate medical attention:

  • Allergic reaction: seek immediate medical attention for symptoms such as severe swelling or anaphylaxis. 
  • Ketoacidosis: a rare but life-threatening condition where blood becomes too acidic.
  • Severe Hypotension: caused by excessive fluid loss.

Risk Management

  • Stay hydrated to minimize dehydration risks.

Report any unusual symptoms, such as difficulty breathing or severe abdominal pain, to a healthcare provider immediately.

Drug and Testing Interactions with Farxiga (Dapagliflozin)

Farxiga (dapagliflozin) can interact with some medications and tests, which may impact its effectiveness, increase the risk of side effects, or affect certain laboratory test results. 

It is essential for patients and clinicians to be aware of these potential interactions to ensure safe and effective use. The following may interact with Farxiga:

Medications That May Increase the Risk of Hypoglycemia

When taken alongside other blood sugar-lowering medications, Farxiga can increase the risk of hypoglycemia (low blood sugar). These medications include:

Insulin

Combining insulin with Farxiga may require dose adjustments to prevent hypoglycemia.

Sulfonylureas (e.g., glipizide, glyburide)

These medications also lower blood sugar, increasing the likelihood of low glucose levels when used together with Farxiga.

Lithium

Farxiga may lower lithium levels. This interaction requires close monitoring to prevent lithium toxicity or reduced therapeutic effects.

Urine Glucose Tests

Farxiga increases urinary glucose excretion, causing false-positive results in urine glucose tests. It’s recommended that patients using Farxiga use alternative methods to monitor glycemic control.

1,5-Anhydroglucitol (1,5-AG) Assay

This test is unreliable for glycemic control monitoring in patients on Farxiga. Avoid using the 1,5-AG assay in these patients; opt for alternative monitoring methods.

Farxiga vs. Other Diabetes Medications

Here is a comparative analysis of Farxiga vs. other common diabetes treatments:

Comparative Analysis

  • Farxiga vs. Metformin: while metformin is a first-line treatment, Farxiga offers added cardiovascular and kidney benefits.
  • Farxiga vs. GLP-1 Agonists: GLP-1 drugs focus more on weight loss and appetite control, whereas Farxiga targets glucose excretion and organ protection.

Combination Therapy

Farxiga is often combined with other medications like metformin or GLP-1 agonists to enhance diabetes management.

Diet and Lifestyle Measures to Support Healthy Blood Sugar Levels

While medications can be important to manage blood sugar levels, diet and lifestyle are also foundational to healthy blood sugar.

Diet Tips

Diet is the essential piece to maintaining healthy blood sugar levels and increasing insulin sensitivity.

Focus on Low-Glycemic Foods

Incorporate foods that cause a slow and steady rise in blood sugar such as whole grains, non-starchy vegetables, legumes, and nuts.

Balance Macronutrients

Pair carbohydrates with protein and healthy fats to slow glucose absorption and prevent blood sugar spikes.

Increase Fiber Intake

Aim for 25-35 grams of fiber per day from sources like vegetables, fruits, beans, and seeds.

Reduce Added Sugars

Limit sugary snacks, desserts, and beverages, replacing them with naturally sweet options like fruit and low-glycemic carbohydrates.

Practice Portion Control

Eat smaller, frequent meals to avoid large blood sugar fluctuations.

Stay Hydrated

Drink plenty of water throughout the day, as dehydration can impact blood sugar regulation.

Moderate Alcohol Consumption

Limit alcohol intake, as it can cause unpredictable changes in blood sugar levels in diabetic patients.

Lifestyle Strategies

The following strategies help reduce blood sugar levels and can also increase insulin sensitivity.

Exercise Regularly

Engage in at least 150 minutes of moderate aerobic activity per week, such as brisk walking, cycling, or swimming, to improve insulin sensitivity.

Incorporate Strength Training

Build muscle mass through weightlifting or resistance exercises, as muscles help regulate glucose uptake.

Manage Stress

Practice relaxation techniques like yoga, meditation, or deep breathing to reduce cortisol levels, which can negatively impact blood sugar.

Prioritize Sleep

Aim for 7-9 hours of quality sleep nightly, as poor sleep can impair glucose metabolism and increase insulin resistance.

Monitor Blood Sugar Levels

Regular tracking helps identify patterns, provides accountability, and encourages you to adjust diet and lifestyle strategies accordingly.

Quit Smoking

Smoking worsens insulin resistance and increases the risk of complications like heart disease.

Key Supplements

Some supplements may support healthy blood sugar levels alongside diet, lifestyle, and appropriate medications. Always speak with your doctor before beginning any new supplements.

Cinnamon

Cinnamon may help improve insulin sensitivity and reduce fasting blood sugar levels. Look for cassia or Ceylon cinnamon in capsule form or as a powder.

Chromium

Chromium supports insulin function and glucose metabolism, and can help improve glucose control over time.

Berberine

Berberine is a plant compound that may lower blood sugar by improving insulin sensitivity and reducing glucose production in the liver. 

FAQs About Farxiga (Dapagliflozin)

The following section is a quick reference for people with specific questions. 

What Is Farxiga Used For?

Farxiga is used to lower blood sugar in Type 2 diabetes, reduce heart failure hospitalizations, and slow chronic kidney disease progression.

What Are The Most Common Side Effects of Farxiga?

UTIs, yeast infections, and dehydration are the most common side effects.

What should I avoid when taking Farxiga?

Avoid excessive alcohol and dehydration to reduce the risk of serious side effects.

Is weight loss guaranteed with Farxiga?

While many patients experience moderate weight loss, it is not guaranteed.

Can Farxiga be used in Type 1 diabetes?

No, Farxiga is contraindicated in Type 1 diabetes due to the risk of ketoacidosis.

[signup]

Key Takeaways

  • Diabetes Surge: Global diabetes cases have quadrupled since 1990, now affecting ~800 million.
  • Farxiga Role: An SGLT2 inhibitor that lowers blood sugar and supports heart and kidney health.
  • FDA Approvals: Treats Type 2 diabetes, reduces heart failure hospitalizations, and slows kidney disease.
  • Mechanism: Prevents glucose reabsorption in kidneys, lowering blood sugar and fluid retention.
  • Primary Benefits:
    • Lowers HbA1c
    • Reduces heart-related deaths
    • Slows kidney disease progression
    • Aids in weight loss
  • Who Should Use: Adults with Type 2 diabetes, heart failure, or chronic kidney disease.
  • Dosage: Starts at 5 mg once daily, adjustable as needed.
  • Common Side Effects: UTIs, yeast infections, dehydration.
  • Serious Risks: Allergic reactions, ketoacidosis, kidney injury.
  • Interactions: Increases hypoglycemia risk with insulin/sulfonylureas; affects lithium levels and certain tests.
  • Lifestyle Integration: Effective with diet, exercise, hydration, and stress management.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

6 FARXIGA ® (dapagliflozin) MEDICATION GUIDE FARXIGA ® (FAR-SEE-GUH) (dapagliflozin) tablets, for oral use. (n.d.). https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/0be9cb1b-3b33-41c7-bfc2-04c9f718e442/0be9cb1b-3b33-41c7-bfc2-04c9f718e442_pi_med_guide_rendition__c.pdf

Albarrán, O. G., & Ampudia-Blasco, F. J. (2013). Dapagliflozina, el primer inhibidor SGLT 2 en el tratamiento de la diabetes tipo 2 [Dapagliflozin, the first SGLT-2 inhibitor in the treatment of type 2 diabetes]. Medicina clinica, 141 Suppl 2, 36–43. https://doi.org/10.1016/S0025-7753(13)70062-9

Anderson, S. (2022, September 14). This is What Happens to Your Body When You are Dehydrated. Rupa Health. https://www.rupahealth.com/post/this-is-what-happens-to-your-body-when-you-are-dehydrated 

Bergman, B. C., Perreault, L., Hunerdosse, D., Kerege, A., Playdon, M., Samek, A. M., & Eckel, R. H. (2012). Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes, 61(12), 3156–3166. https://doi.org/10.2337/db12-0418

Bryant, A. (2024, September 2). How to Have a Good Night Sleep: Top Proven Strategies for Better Rest. Rupa Health. https://www.rupahealth.com/post/how-to-have-a-good-night-sleep-top-proven-strategies-for-better-rest 

Busch, R. S., & Kane, M. P. (2017). Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes. Postgraduate Medicine, 129(7), 686–697. https://doi.org/10.1080/00325481.2017.1342509

Cao, C., & Su, M. (2019). Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome. Experimental and therapeutic medicine, 17(4), 3009–3014. https://doi.org/10.3892/etm.2019.7295

Chen, J. F., Peng, Y. S., Chen, C. S., Tseng, C. H., Chen, P. C., Lee, T. I., Lu, Y. C., Yang, Y. S., Lin, C. L., Hung, Y. J., Chen, S. T., Lu, C. H., Yang, C. Y., Chen, C. C., Lee, C. C., Hsiao, P. J., Jiang, J. Y., & Tu, S. T. (2020). Use and effectiveness of dapagliflozin in patients with type 2 diabetes mellitus: a multicenter retrospective study in Taiwan. PeerJ, 8, e9998. https://doi.org/10.7717/peerj.9998

Cleveland Clinic. (2023, July 3). GLP-1 Agonists. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists

Cloyd, J. (2023, July 13). A Functional Medicine UTI Protocol: Specialized Testing, Therapeutic Diet, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-uti-protocol-specialized-testing-therapeutic-diet-and-supplements 

Cloyd, J. A Functional Medicine Vaginal Yeast Infection Protocol: Comprehensive Testing, Therapeutic Dietary Guidance, and Supplements. (2023, July 14). Rupa Health. https://www.rupahealth.com/post/a-fuctional-medicine-vaginal-yeast-infection-protocol-comprehensive-testing-therapeutic-dietary-guidance-and-supplements 

Cloyd, J. (2023, May 17). The Role Of Nutrition And Dietary Supplements In Preventing And Managing Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/the-role-of-nutrition-and-dietary-supplements-in-preventing-and-managing-cardiovascular-disease 

Cloyd J. The Science of Hydration: How Water Intake Affects Overall Health. Rupa Health. Published January 8, 2024. https://www.rupahealth.com/post/the-science-of-hydration-how-water-intake-affects-overall-health 

Cloyd, K. (2023, December 7). Cardiovascular Disease and Metabolic Syndrome: Addressing Root Causes with Functional Medicine. Rupa Health. https://www.rupahealth.com/post/cardiovascular-disease-and-metabolic-syndrome-addressing-root-causes-with-functional-medicine 

Common questions about dapagliflozin. (2022, March 3). Nhs.uk. https://www.nhs.uk/medicines/dapagliflozin/common-questions-about-dapagliflozin/

Cox, A. D. (2022, September 8). 4 Herbs And Supplements That May Help Control Type 1 Diabetes. Rupa Health. https://www.rupahealth.com/post/a-root-cause-approach-to-managing-type-1-diabetes 

Dapagliflozin: MedlinePlus Drug Information. (n.d.). Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a614015.html

Dapagliflozin (Farxiga): Uses & Side Effects. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/19382-dapagliflozin-tablets

Emanuele, N. V., Swade, T. F., & Emanuele, M. A. (1998). Consequences of alcohol use in diabetics. Alcohol health and research world, 22(3), 211–219.

Farxiga. HIGHLIGHTS OF PRESCRIBING INFORMATION. (n.d.). https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202293s031lbl.pdf

Glycemic index and diabetes: MedlinePlus Medical Encyclopedia. (n.d.). Medlineplus.gov. https://medlineplus.gov/ency/patientinstructions/000941.htm

Havel P. J. (2004). A scientific review: the role of chromium in insulin resistance. The Diabetes educator, Suppl, 2–14.

He, K., Li, J., Xi, W., Ge, J., Sun, J., & Jing, Z. (2022). Dapagliflozin for nonalcoholic fatty liver disease: A systematic review and meta-analysis. Diabetes research and clinical practice, 185, 109791. https://doi.org/10.1016/j.diabres.2022.109791

Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F. F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., Sjöström, C. D., Toto, R. D., Langkilde, A. M., Wheeler, D. C., & DAPA-CKD Trial Committees and Investigators (2020). Dapagliflozin in Patients with Chronic Kidney Disease. The New England journal of medicine, 383(15), 1436–1446. https://doi.org/10.1056/NEJMoa2024816

Khakham, C. (2023, March 28). An integrative medicine approach to kidney disease. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-kidney-disease 

Maholy, N. (2023, April 14). How to reduce stress through mind-body therapies. Rupa Health. https://www.rupahealth.com/post/how-to-reduce-stress-through-mind-body-therapies 

McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., Böhm, M., Chiang, C.-E., Chopra, V. K., de Boer, R. A., Desai, A. S., Diez, M., Drozdz, J., Dukát, A., Ge, J., & Howlett, J. G. (2019). Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine, 381(21). https://doi.org/10.1056/nejmoa1911303

MedLine Plus. (2020, March 15). Metformin: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a696005.html

Neibling, K. (2023, April 26). Complementary and Integrative Medicine Treatments for Hypertension and Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatments-for-hypertension-and-cardiovascular-disease 

Office of the Commissioner. (2020, May 22). FDA approves new treatment for a type of heart failure. FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-type-heart-failure

Ohara, K., Masuda, T., Morinari, M., Okada, M., Miki, A., Nakagawa, S., Murakami, T., Oka, K., Asakura, M., Miyazawa, Y., Maeshima, A., Akimoto, T., Saito, O., & Nagata, D. (2020). The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease. Diabetology & Metabolic Syndrome, 12(1). https://doi.org/10.1186/s13098-020-00545-z

Perera, H. (2024, April 11). The Ultimate Fiber Foods List: Boost Your Health with High-Fiber Choices. Rupa Health. https://www.rupahealth.com/post/ultimate-fiber-foods-list 

Qin, B., Panickar, K. S., & Anderson, R. A. (2010). Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. Journal of diabetes science and technology, 4(3), 685–693. https://doi.org/10.1177/193229681000400324

Rupa Health. (n.d.). Insulin. Rupa Health. https://www.rupahealth.com/biomarkers/insulin 

Sugiyama, S., Jinnouchi, H., Kurinami, N., Hieshima, K., Yoshida, A., Jinnouchi, K., Nishimura, H., Suzuki, T., Miyamoto, F., Kajiwara, K., & Jinnouchi, T. (2018). Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes. Journal of atherosclerosis and thrombosis, 25(6), 467–476. https://doi.org/10.5551/jat.40873

Tan, X., & Hu, J. (2015). Combination therapy for type 2 diabetes: dapagliflozin plus metformin. Expert Opinion on Pharmacotherapy, 17(1), 117–126. https://doi.org/10.1517/14656566.2016.1121235

Yoshimura, H. (2024, April 12). Nutritional interventions in heart failure care. Rupa Health. https://www.rupahealth.com/post/nutritional-interventions-in-heart-failure-care 

Yoshimura, H. (2023, November 13). Sweat It Out: The Powerful Connection Between Exercise and Insulin Sensitivity. Rupa Health. https://www.rupahealth.com/post/sweat-it-out-the-powerful-connection-between-exercise-and-insulin-sensitivity 

Zhou, B., Rayner, A. W., Gregg, E. W., Sheffer, K. E., Carrillo-Larco, R. M., Bennett, J. E., Shaw, J. E., Paciorek, C. J., Singleton, R. K., Pires, A. B., Stevens, G. A., Goodarz Danaei, Lhoste, V. P., Phelps, N. H., Heap, R. A., Jain, L., De, D., Galeazzi, A., Kengne, A. P., & Mishra, A. (2024). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. The Lancet, 404(10467). https://doi.org/10.1016/s0140-6736(24)02317-1

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.